An Innovative Terahertz-Based Real-Time Tissue Imaging Device for Surgical Guidance
Cancer Cases
Cancer Deaths
Approximately > 3,90,000 cancer surgeries in a year in India
Conventional Process : Pathology Assessment
Conventional Process : Pathology Assessment
Current diagnostic procedure “Frozen Section Analysis” is conventionally used in hospitals. It requires freezing the tissue, slicing and then waiting for an pathologist for the confirmation.
Most of the small and medium hospitals rely on Histopathology analysis, which takes 5 to 7 days depending on the availability of the pathologists.
Current Approach
- Time Consuming
- Need of expert Pathologist
- Postoperative Procedure
- Recurrence
TeraMargin™
An Alternate potential reagent free solution for Accurate Cancer Margin Detection
Combining cutting edge Terahertz Technology, with Advanced Machine Learning to transform cancer surgery
Precise
Reagents Free
Rapid (Within 10 mins)
Tera Margin Process
Tera Margin Process
TeraMargin™ Validated with
100+ Head and Neck Fresh
tissue samples
75+ Breast Cancer
Tissue Samples
TeraLumen Has Developed
TeraMargin
TeraMargin, a patented device, can precisely segment regions with and without tumors while performing real-time imaging without touching the tissue.
TeraSoft
In-built Graphical User Interface to display the real time tissue images, mapped with visible image
Clinical Decision
We are attempting to utilize our cutting-edge artificial intelligence algorithm to attain sensitivity and specificity of above 90 percent.
Collaborators
